Global Recombinant Protein Customization Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI08257239

Publication Date:

August 11, 2025

Pages:

150

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

According to this study, the global Recombinant Protein Customization Service market size will reach US$ 11713 million by 2031.
Recombinant protein customization service is aimed at specific proteins. Contract research/production organizations provide one-stop customized services including gene synthesis, expression vector construction, expression system screening (such as E. coli, yeast, insect or mammalian cells), purification process development, modification (such as labeling, glycosylation, label removal, etc.) and quality analysis based on the sequence or functional requirements provided by customers. This service is widely used in antibody drug development, vaccine research, structural biology, protein-protein interaction research, enzyme engineering, diagnostic reagents and other fields, and is one of the key technical supports for basic research and industrialization of biomedicine.
United States market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Recombinant Protein Customization Service players cover ProteoGenix, Bio-Techne, VectorBuilder Inc, Biocompare, Biomatik, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淩ecombinant Protein Customization Service Industry Forecast鈥� looks at past sales and reviews total world Recombinant Protein Customization Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Protein Customization Service sales for 2025 through 2031. With Recombinant Protein Customization Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Protein Customization Service industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Protein Customization Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Protein Customization Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Recombinant Protein Customization Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Protein Customization Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Protein Customization Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Customization Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Purity 鈮� 85%
Purity 鈮� 95%
Purity 鈮� 98%
Others
Segmentation by Application:
Pharmaceutical Companies
Biological Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ProteoGenix
Bio-Techne
VectorBuilder Inc
Biocompare
Biomatik
Eurofins Discovery
ProMab
Thermo Fisher
RayBiotech
Akron Biotech
AGC Biologics
OriGene
Calixar
Hzymes Biotechnology
Mabioway
Genscript
Abace Biotechnology
Sino Biological
Detai Bioscience
ACROBiosystems
UA BIOSCIENCE
Cusabio

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Recombinant Protein Customization Service 麻豆原创 Size (2020-2031)
2.1.2 Recombinant Protein Customization Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Recombinant Protein Customization Service by Country/Region (2020, 2024 & 2031)
2.2 Recombinant Protein Customization Service Segment by Type
2.2.1 Purity 鈮� 85%
2.2.2 Purity 鈮� 95%
2.2.3 Purity 鈮� 98%
2.2.4 Others
2.3 Recombinant Protein Customization Service 麻豆原创 Size by Type
2.3.1 Recombinant Protein Customization Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Recombinant Protein Customization Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Recombinant Protein Customization Service Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Biological Laboratories
2.4.3 Others
2.5 Recombinant Protein Customization Service 麻豆原创 Size by Application
2.5.1 Recombinant Protein Customization Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Recombinant Protein Customization Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Recombinant Protein Customization Service 麻豆原创 Size by Player
3.1 Recombinant Protein Customization Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Recombinant Protein Customization Service Revenue by Player (2020-2025)
3.1.2 Global Recombinant Protein Customization Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Recombinant Protein Customization Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Recombinant Protein Customization Service by Region
4.1 Recombinant Protein Customization Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Recombinant Protein Customization Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Recombinant Protein Customization Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Recombinant Protein Customization Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Recombinant Protein Customization Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Recombinant Protein Customization Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Recombinant Protein Customization Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Recombinant Protein Customization Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Recombinant Protein Customization Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Protein Customization Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Recombinant Protein Customization Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Recombinant Protein Customization Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Recombinant Protein Customization Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Recombinant Protein Customization Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Recombinant Protein Customization Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Protein Customization Service by Region (2020-2025)
8.2 Middle East & Africa Recombinant Protein Customization Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Recombinant Protein Customization Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Recombinant Protein Customization Service 麻豆原创 Forecast
10.1 Global Recombinant Protein Customization Service Forecast by Region (2026-2031)
10.1.1 Global Recombinant Protein Customization Service Forecast by Region (2026-2031)
10.1.2 Americas Recombinant Protein Customization Service Forecast
10.1.3 APAC Recombinant Protein Customization Service Forecast
10.1.4 Europe Recombinant Protein Customization Service Forecast
10.1.5 Middle East & Africa Recombinant Protein Customization Service Forecast
10.2 Americas Recombinant Protein Customization Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Recombinant Protein Customization Service Forecast
10.2.2 Canada 麻豆原创 Recombinant Protein Customization Service Forecast
10.2.3 Mexico 麻豆原创 Recombinant Protein Customization Service Forecast
10.2.4 Brazil 麻豆原创 Recombinant Protein Customization Service Forecast
10.3 APAC Recombinant Protein Customization Service Forecast by Region (2026-2031)
10.3.1 China Recombinant Protein Customization Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Recombinant Protein Customization Service Forecast
10.3.3 Korea 麻豆原创 Recombinant Protein Customization Service Forecast
10.3.4 Southeast Asia 麻豆原创 Recombinant Protein Customization Service Forecast
10.3.5 India 麻豆原创 Recombinant Protein Customization Service Forecast
10.3.6 Australia 麻豆原创 Recombinant Protein Customization Service Forecast
10.4 Europe Recombinant Protein Customization Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Recombinant Protein Customization Service Forecast
10.4.2 France 麻豆原创 Recombinant Protein Customization Service Forecast
10.4.3 UK 麻豆原创 Recombinant Protein Customization Service Forecast
10.4.4 Italy 麻豆原创 Recombinant Protein Customization Service Forecast
10.4.5 Russia 麻豆原创 Recombinant Protein Customization Service Forecast
10.5 Middle East & Africa Recombinant Protein Customization Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Recombinant Protein Customization Service Forecast
10.5.2 South Africa 麻豆原创 Recombinant Protein Customization Service Forecast
10.5.3 Israel 麻豆原创 Recombinant Protein Customization Service Forecast
10.5.4 Turkey 麻豆原创 Recombinant Protein Customization Service Forecast
10.6 Global Recombinant Protein Customization Service Forecast by Type (2026-2031)
10.7 Global Recombinant Protein Customization Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Recombinant Protein Customization Service Forecast
11 Key Players Analysis
11.1 ProteoGenix
11.1.1 ProteoGenix Company Information
11.1.2 ProteoGenix Recombinant Protein Customization Service Product Offered
11.1.3 ProteoGenix Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 ProteoGenix Main Business Overview
11.1.5 ProteoGenix Latest Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Company Information
11.2.2 Bio-Techne Recombinant Protein Customization Service Product Offered
11.2.3 Bio-Techne Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Bio-Techne Main Business Overview
11.2.5 Bio-Techne Latest Developments
11.3 VectorBuilder Inc
11.3.1 VectorBuilder Inc Company Information
11.3.2 VectorBuilder Inc Recombinant Protein Customization Service Product Offered
11.3.3 VectorBuilder Inc Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 VectorBuilder Inc Main Business Overview
11.3.5 VectorBuilder Inc Latest Developments
11.4 Biocompare
11.4.1 Biocompare Company Information
11.4.2 Biocompare Recombinant Protein Customization Service Product Offered
11.4.3 Biocompare Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Biocompare Main Business Overview
11.4.5 Biocompare Latest Developments
11.5 Biomatik
11.5.1 Biomatik Company Information
11.5.2 Biomatik Recombinant Protein Customization Service Product Offered
11.5.3 Biomatik Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Biomatik Main Business Overview
11.5.5 Biomatik Latest Developments
11.6 Eurofins Discovery
11.6.1 Eurofins Discovery Company Information
11.6.2 Eurofins Discovery Recombinant Protein Customization Service Product Offered
11.6.3 Eurofins Discovery Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Eurofins Discovery Main Business Overview
11.6.5 Eurofins Discovery Latest Developments
11.7 ProMab
11.7.1 ProMab Company Information
11.7.2 ProMab Recombinant Protein Customization Service Product Offered
11.7.3 ProMab Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 ProMab Main Business Overview
11.7.5 ProMab Latest Developments
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Information
11.8.2 Thermo Fisher Recombinant Protein Customization Service Product Offered
11.8.3 Thermo Fisher Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Thermo Fisher Main Business Overview
11.8.5 Thermo Fisher Latest Developments
11.9 RayBiotech
11.9.1 RayBiotech Company Information
11.9.2 RayBiotech Recombinant Protein Customization Service Product Offered
11.9.3 RayBiotech Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 RayBiotech Main Business Overview
11.9.5 RayBiotech Latest Developments
11.10 Akron Biotech
11.10.1 Akron Biotech Company Information
11.10.2 Akron Biotech Recombinant Protein Customization Service Product Offered
11.10.3 Akron Biotech Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Akron Biotech Main Business Overview
11.10.5 Akron Biotech Latest Developments
11.11 AGC Biologics
11.11.1 AGC Biologics Company Information
11.11.2 AGC Biologics Recombinant Protein Customization Service Product Offered
11.11.3 AGC Biologics Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 AGC Biologics Main Business Overview
11.11.5 AGC Biologics Latest Developments
11.12 OriGene
11.12.1 OriGene Company Information
11.12.2 OriGene Recombinant Protein Customization Service Product Offered
11.12.3 OriGene Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 OriGene Main Business Overview
11.12.5 OriGene Latest Developments
11.13 Calixar
11.13.1 Calixar Company Information
11.13.2 Calixar Recombinant Protein Customization Service Product Offered
11.13.3 Calixar Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Calixar Main Business Overview
11.13.5 Calixar Latest Developments
11.14 Hzymes Biotechnology
11.14.1 Hzymes Biotechnology Company Information
11.14.2 Hzymes Biotechnology Recombinant Protein Customization Service Product Offered
11.14.3 Hzymes Biotechnology Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Hzymes Biotechnology Main Business Overview
11.14.5 Hzymes Biotechnology Latest Developments
11.15 Mabioway
11.15.1 Mabioway Company Information
11.15.2 Mabioway Recombinant Protein Customization Service Product Offered
11.15.3 Mabioway Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Mabioway Main Business Overview
11.15.5 Mabioway Latest Developments
11.16 Genscript
11.16.1 Genscript Company Information
11.16.2 Genscript Recombinant Protein Customization Service Product Offered
11.16.3 Genscript Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Genscript Main Business Overview
11.16.5 Genscript Latest Developments
11.17 Abace Biotechnology
11.17.1 Abace Biotechnology Company Information
11.17.2 Abace Biotechnology Recombinant Protein Customization Service Product Offered
11.17.3 Abace Biotechnology Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Abace Biotechnology Main Business Overview
11.17.5 Abace Biotechnology Latest Developments
11.18 Sino Biological
11.18.1 Sino Biological Company Information
11.18.2 Sino Biological Recombinant Protein Customization Service Product Offered
11.18.3 Sino Biological Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Sino Biological Main Business Overview
11.18.5 Sino Biological Latest Developments
11.19 Detai Bioscience
11.19.1 Detai Bioscience Company Information
11.19.2 Detai Bioscience Recombinant Protein Customization Service Product Offered
11.19.3 Detai Bioscience Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Detai Bioscience Main Business Overview
11.19.5 Detai Bioscience Latest Developments
11.20 ACROBiosystems
11.20.1 ACROBiosystems Company Information
11.20.2 ACROBiosystems Recombinant Protein Customization Service Product Offered
11.20.3 ACROBiosystems Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 ACROBiosystems Main Business Overview
11.20.5 ACROBiosystems Latest Developments
11.21 UA BIOSCIENCE
11.21.1 UA BIOSCIENCE Company Information
11.21.2 UA BIOSCIENCE Recombinant Protein Customization Service Product Offered
11.21.3 UA BIOSCIENCE Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 UA BIOSCIENCE Main Business Overview
11.21.5 UA BIOSCIENCE Latest Developments
11.22 Cusabio
11.22.1 Cusabio Company Information
11.22.2 Cusabio Recombinant Protein Customization Service Product Offered
11.22.3 Cusabio Recombinant Protein Customization Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 Cusabio Main Business Overview
11.22.5 Cusabio Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.